Form 4: T2 Biosystems Director Receives 25,000 Restricted Stock Units

A T2 Biosystems director, Ninfa Saunders, was granted 25,000 restricted stock units (RSUs) that vest in two equal annual installments starting November 4, 2025.

Summary

• Ninfa Saunders, a director at T2 Biosystems, received 25,000 restricted stock units (RSUs) on November 4, 2024.
• These RSUs will vest in two equal annual installments, beginning on November 4, 2025.
• Each RSU represents a contingent right to receive one share of T2 Biosystems common stock.
• The grant was contingent on stockholder approval of the amendment and restatement of the company's 2014 Incentive Award Plan.
• Stockholder approval for the plan amendment was obtained on December 30, 2024.

Sentiment

Score: 7

Explanation: The document reflects a standard compensation practice, which is generally viewed positively as it aligns director interests with shareholders. There are no negative implications.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The RSUs will vest in two equal annual installments beginning on November 4, 2025.

Industry Context

The granting of RSUs is a common practice for compensating directors and aligning their interests with shareholders in the biotechnology industry.

Comparison to Industry Standards

• RSU grants are a standard form of equity compensation for directors in publicly traded companies, particularly in the biotech sector.
• Vesting schedules, such as the two-year annual installment plan, are typical to encourage long-term commitment and performance.
• Companies like Exact Sciences and Bio-Rad Laboratories also use similar equity-based compensation for their board members.

Stakeholder Impact

• Shareholders may view the RSU grant positively as it aligns the director's interests with the company's long-term success.
• The vesting schedule encourages the director's continued service and contribution to the company.

Key Dates

Keywords

Restricted Stock Units, RSU, Director Compensation, Stock Options, Incentive Award Plan, T2 Biosystems, TTOO, Equity Compensation